Use access key #2 to skip to page content.
$10.27 -0.63 (-5.78%)
1/9/2009 4:00 PM

Alkermes, Inc. (ALKS)

CAPS Rating:
****

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

View All Commentary (ALKS)

Recs

1

Avatar dcl12 (90.70) Submitted: 1/24/07 8:26 PM : Outperform Start Price: $14.60 ALKS Score: 8.41

There are many analysis in more depth than what I can add though it is worth noting that ALKS has big pharma partners. The pipeline is strong.

I think we will see another shake out dip (~$12-$13 ) in the stock before we see the major investment houses buy up all they can as low as they can drive it.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links